Arm CEO Says AI Could Help Cure Cancer, but Data Centers Are Straining Chip Supply

Arm CEO Rene Haas said AI could help humanity cure cancer within our lifetimes, calling health the “killer app” for AI in an interview with the BBC. He said AI could shorten both the time needed to invent drugs and the time needed to test them. Haas has led Arm since February 2022 after joining the British chip designer in 2013, and previously spent seven years at Nvidia.

Haas said reaching that health breakthrough would require enormous computing power. He warned that chips needed for cancer research and humanoid development are being consumed by AI companies planning data centers measured in multiple gigawatts. He described the industry as “absolutely supply-constrained” and said more fabrication plants are needed, noting that fabs can cost tens of billions of dollars and take two or three years to build.

The article notes that even without the chip bottleneck, AI curing cancer in the next few years is far from certain. Cancer is not a single disease but a collection of more than 100 diseases that vary across patients. AI can help identify targets and predict how drugs might behave, but evidence of clinically relevant impact remains limited, and human biological variation makes reliable prediction difficult.

Other chip executives have raised similar concerns about shortages, including Micron COO Manish Bhatia on memory and Qualcomm CEO Cristiano Amon on industry-wide memory shortages and price increases. In the US, data center construction has surged, with more than 1,400 built or approved for build-outs by the end of last year. The expansion has become divisive because of concerns about air and water quality, and a Gallup survey of 1,000 US adults found seven in 10 opposed AI data centers in their local area, with nearly half strongly opposed.